Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Use of tocilizumab and sarilumab alone or in...
Journal article

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis

Abstract

Objective: To compare the effects of interleukin 6 receptor blockers, tocilizumab and sarilumab, with or without corticosteroids, on mortality in patients with covid-19. Design: Systematic review and network meta-analysis.

Authors

Zeraatkar D; Cusano E; Martínez JPD; Qasim A; Mangala S; Kum E; Bartoszko JJ; Devji T; Agoritsas T; Guyatt G

Journal

BMJ Medicine, Vol. 1, No. 1,

Publisher

BMJ

Publication Date

March 2022

DOI

10.1136/bmjmed-2021-000036

ISSN

2754-0413

Labels

Sustainable Development Goals (SDG)